The Triphasic Group is an engineering company specializing in solving
fluid and haemodynamic energy challenges through collaboration with
clinicians, researchers and device manufacturers.
​
The Triphasic Innovation is a world’s first, cost-effective pulsatile pump
offering a novel solution for complexities in both laboratory and clinical settings.
TriLab 250 pump
Mono, Bi, Triphasic
The pump is able to produce monophasic, biphasic and triphasic wave
forms which allow a number of unique medical and research
applications.
Patented Technology
State of the art, novel solutions
Patent submissions
WO/2019/136520 WO/2021/051170
US 20210361928 EP3737438 CA3088013 AU2019207523 AU2018901176 AU2018900086
AU2020348499 BR112022005088 IN202237016996 AU2019903484 US20220370785 EP4037722
TriLab 250
Mono, bi and triphasic flow pump for
research, simulation training
and product testing
In the final stages of commercialization
TriClinic
Perfusion circuit in CPB and life support
Improving control of oxygenation &
efficiency of pulse delivery
Proof-of-concept completed, validation stage
ToeFlo MI & NI
Non and minimally invasive treatment for
treating slow & non-healing wounds
in limb salvage and amputation prevention
Proof-of-concept stage
TriVAD
Patient specific ventricular assist device
Improving control of oxygenation & efficiency of
pulse delivery without drivelines
Proof-of-concept stage
Australia, Brazil, Canada, China, Europe Germany, Italy, India, Japan, Korea, USA
Patent Distributions
TriLab 250
Mono, Bi and Triphasic
Pre-orders & leasing enquiries welcome
News and Publications
1. A Pulsatile Pump for Cardiac Surgery
2. Development of a triphasic pulsatile flow phantom for experimental study of abdominal aortic blood flow
Get in Touch
Contact:
Dr. Albert Chong
CEO and Chief Innovation Officer
albert.chong@triphasic.com.au
+61-1300 797789
+61-428-537-287
Australia:
Level 1, 22 Stirling Highway,
Nedlands WA 6009, Australia​
Singapore:
Level 1, 22 Stirling Highway,
Nedlands WA 6009, Australia​
